Actively Recruiting
Studying Age Differences in Immune Responses to Seasonal Flu and Rabies Vaccines in Adults
Led by Washington University School of Medicine · Updated on 2026-11-03
40
Participants Needed
1
Research Sites
33 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating how the immune system responds to vaccination against influenza and rabies in healthy adults. The study focuses on understanding how immune responses develop and change over time in the blood and lymph nodes after vaccination with two FDA-approved vaccines the seasonal trivalent influenza vaccine TIV and the rabies vaccine RabAvert. The goal is to learn how the body produces strong, lasting antibody and memory immune responses and to compare these responses between younger and older adults, as immune function may decline with age. Participants will receive the standard seasonal flu vaccine and the RabAvert rabies vaccine. The study involves vaccination and subsequent monitoring of immune responses over time. The main period of observation follows vaccination day 1 up to day 29 to assess rabies-specific antibody levels compared to baseline. The study is conducted as a single group intervention without masking. During the study, participants will provide blood samples and may optionally give lymph node fine needle aspiration samples to analyze immune responses. Researchers will measure rabies-specific antibody titers from vaccination day 1 to day 29. Participants will be monitored for safety and immune response changes during this period. The total participation duration is approximately one month, with no long-term extension mentioned.
CONDITIONS
Brief Title
Age-Associated Differences in Germinal Center Responses to Influenza and Rabies Vaccination in Humans
Research Team
P
Patrick Olson, MD
R
Rachel Presti, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here